Compare Illumina, Inc. (ILMN) vs Intel Corp (INTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Intel Corp — how do they compare? Illumina, Inc. trades at $278.17 (market cap $39.95B), while Intel Corp trades at $104.7 (market cap $566.04B). The key difference: Intel Corp is far larger — about 14.2× Illumina, Inc.'s market cap, and Intel Corp pays a 2.24% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Intel Corp for 116 Days on average.
| ILMN | INTC | |
|---|---|---|
Market Cap | $39.95B | $566.04B |
Volume | 3,169,503 | 118,475,837 |
Sector | Health | Technology |
52-Week High | $293.69 | $140.94 |
52-Week Low | $91.00 | $33.62 |
Typical Hold Time | 83 Days | 116 Days |
Enterprise Value | $41.31B | $586.85B |
Dividend Yield | — | 2.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $264.40, down 1.25% on the day but remains near its 52-week high of $278.99, reflecting strong momentum with a 94.9% YTD gain. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Fundamentals show a significant turnaround, with net income reaching $850 million in 2025 after prior losses, supported by robust gross margins of 66.38%. Technical indicators are bullish overall, with key support at $257 and resistance at $268.
The outlook for ILMN is positive, driven by earnings momentum, inclusion in the S&P 500, and strategic AI initiatives in genomics. However, risks include high valuation multiples, such as a P/E of 49.36, and potential margin pressure from cost volatility. Analyst consensus is bullish with a 54% buy rating, though the consensus price target of $241 suggests limited near-term upside from current levels.
Intel (INTC) trades at $107.08, down 5.34% today, but maintains a bullish technical outlook with strong support at $104. The stock has surged over 220% year-to-date amid AI-driven momentum. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $0.42 exceeding estimates. However, the company posted a net loss of -$267 million in 2025, reflecting margin pressures. Cash flow improved with $6.46 billion net inflow in 2025, though debt levels remain elevated.
Intel's turnaround story hinges on its foundry expansion and AI chip demand, but high valuation ratios and negative profitability metrics pose risks. Analyst consensus is cautious with a $111.72 price target and 54% hold ratings. Competitive threats from TSMC and AMD require careful monitoring for sustained growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Intel Corp
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →
